Nucleic Acid Labeling Market Analysis, Global Industry Trends & Forecast, CAGR 7.58% by 2026 - Technavio segmentation based on Application, End-user, and Geography

BY PR Newswire | ECONOMIC | 09/09/22 07:00 AM EDT

NEW YORK, Sept. 9, 2022 /PRNewswire/ -- The nucleic acid labeling market research report provides a detailed analysis of emerging market trends, regional outlook, competitive landscape, and comprehensive analysis of different market segments. The nucleic acid labeling market?is poised to grow by USD 689.47 million from 2021?to 2026,?at a CAGR of?7.58% during the forecast period.?

Attractive Opportunities in Nucleic Acid Labeling Market by Application, End-user, and Geography - Forecast and Analysis 2022-2026

All major aspects that include a detailed analysis of market overview, market drivers, opportunities, and potential applications are covered. Both qualitative & quantitative analyses are focused on the better way to help you with decision-making strategies. View Free Sample Report of Nucleic Acid Labeling Market in MINUTES.

Nucleic Acid Labeling Market Vendors
  • Abcam plc
  • Agilent Technologies Inc.
  • Danaher Corp.
  • Enzo Biochem Inc.
  • Interchim
  • Merck KGaA
  • New England Biolabs Inc.
  • PerkinElmer Inc.
  • Promega Corp.
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories Inc.
  • VWR International LLC

The nucleic acid labeling market will be affected by increasing investment in the development of new biotechnological techniques. Apart from this, other market trends include technological advances in the life sciences industry and the increasing number of applications of molecular biology. Buy Sample Report.

Nucleic Acid Labeling Market Split
  • By Application
    • oligonucleotide labeling
    • in-situ hybridization
    • southern and northern blotting
    • others
  • By End-user
    • diagnostic centers
    • research centers
    • hospitals
  • By Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)


North America will account for 38% of the market's growth over the projection period. The main markets in North America for labeling nucleic acids are the US and Canada. Compared to the markets in Europe and Asia, this region's market will grow more slowly. Over the projection period, the expansion of the nucleic acid labeling market in North America will be aided by the presence of a sizable number of testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical businesses. Download Free Sample Report.

Imperative Insights on the following aspects:

  • What was the size of the global nucleic acid labeling industry by value?
  • What will be the size of the global nucleic acid labeling industry in 2026?
  • What factors are affecting the strength of competition in the global?nucleic acid labeling industry?
  • How has the industry performed over the last five years?
  • What are the main segments that make up the global nucleic acid labeling market?

The product range of the nucleic acid labeling industry is examined based on their production chain, pricing of products, and the profit generated by them. Various regional markets are analyzed in the nucleic acid labeling market research report and the production volume and efficacy across the world are discussed.

Related Reports:
Viral Vectors Market?by Application and Geography - Forecast and Analysis 2022-2026:?The viral vectors market share is expected to increase by USD?490.64 million from 2021 to 2026,?and the market's growth momentum will accelerate at a CAGR of 14.23%.

PCR System for Food Diagnostics Market?by Product and Geography - Forecast and Analysis 2022-2026:?The PCR system for food diagnostics market share is expected to increase by USD?977.11 million from 2021 to 2026,?and the market's growth momentum will accelerate at a CAGR of 8.31%.

Nucleic Acid Labeling Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.58%

Market growth 2022-2026

$ 689.47 million

Market structure

Concentrated

YoY growth (%)

6.75

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abcam plc, Agilent Technologies Inc., Danaher Corp., Enzo Biochem Inc., Interchim, Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., Vector Laboratories Inc., and VWR International LLC

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for?Technavio "Health Care" Research Reports

Table of Content:

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary ? Chart on Market Overview
    • Exhibit 02: Executive Summary ? Data Table on Market Overview
    • Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary ? Chart on Market by Geography
    • Exhibit 05: Executive Summary ? Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary ? Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary ? Chart on Incremental Growth
    • Exhibit 08: Executive Summary ? Data Table on Incremental Growth
    • Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
    • Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
    • Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
    • Exhibit 19: Chart on Bargaining power of buyers ? Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
    • Exhibit 20: Bargaining power of suppliers ? Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
    • Exhibit 21: Threat of new entrants ? Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
    • Exhibit 22: Threat of substitutes ? Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
    • Exhibit 23: Threat of rivalry ? Impact of key factors in 2021 and 2026
  • 4.7 Market condition
    • Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
    • Exhibit 25: Chart on Application - Market share 2021-2026 (%)
    • Exhibit 26: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
    • Exhibit 27: Chart on Comparison by Application
    • Exhibit 28: Data Table on Comparison by Application
  • 5.3 Oligonucleotide labeling - Market size and forecast 2021-2026
    • Exhibit 29: Chart on Oligonucleotide labeling - Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Data Table on Oligonucleotide labeling - Market size and forecast 2021-2026 ($ million)
    • Exhibit 31: Chart on Oligonucleotide labeling - Year-over-year growth 2021-2026 (%)
    • Exhibit 32: Data Table on Oligonucleotide labeling - Year-over-year growth 2021-2026 (%)
  • 5.4 In-situ hybridization - Market size and forecast 2021-2026
    • Exhibit 33: Chart on In-situ hybridization - Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Data Table on In-situ hybridization - Market size and forecast 2021-2026 ($ million)
    • Exhibit 35: Chart on In-situ hybridization - Year-over-year growth 2021-2026 (%)
    • Exhibit 36: Data Table on In-situ hybridization - Year-over-year growth 2021-2026 (%)
  • 5.5 Southern and northern blotting - Market size and forecast 2021-2026
    • Exhibit 37: Chart on Southern and northern blotting - Market size and forecast 2021-2026 ($ million)
    • Exhibit 38: Data Table on Southern and northern blotting - Market size and forecast 2021-2026 ($ million)
    • Exhibit 39: Chart on Southern and northern blotting - Year-over-year growth 2021-2026 (%)
    • Exhibit 40: Data Table on Southern and northern blotting - Year-over-year growth 2021-2026 (%)
  • 5.6 Others - Market size and forecast 2021-2026
    • Exhibit 41: Chart on Others - Market size and forecast 2021-2026 ($ million)
    • Exhibit 42: Data Table on Others - Market size and forecast 2021-2026 ($ million)
    • Exhibit 43: Chart on Others - Year-over-year growth 2021-2026 (%)
    • Exhibit 44: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.7 Market opportunity by Application
    • Exhibit 45: Market opportunity by Application ($ million)

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Exhibit 46: Chart on End-user - Market share 2021-2026 (%)
    • Exhibit 47: Data Table on End-user - Market share 2021-2026 (%)
  • 6.2 Comparison by End-user
    • Exhibit 48: Chart on Comparison by End-user
    • Exhibit 49: Data Table on Comparison by End-user
  • 6.3 Diagnostic centers - Market size and forecast 2021-2026
    • Exhibit 50: Chart on Diagnostic centers - Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on Diagnostic centers - Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on Diagnostic centers - Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on Diagnostic centers - Year-over-year growth 2021-2026 (%)
  • 6.4 Research centers - Market size and forecast 2021-2026
    • Exhibit 54: Chart on Research centers - Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on Research centers - Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on Research centers - Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on Research centers - Year-over-year growth 2021-2026 (%)
  • 6.5 Hospitals - Market size and forecast 2021-2026
    • Exhibit 58: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
  • 6.6 Market opportunity by End-user
    • Exhibit 62: Market opportunity by End-user ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Exhibit 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Exhibit 64: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 65: Data Table on Market share by geography 2021-2026 (%)
  • 8.2 Geographic comparison
    • Exhibit 66: Chart on Geographic comparison
    • Exhibit 67: Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2021-2026
    • Exhibit 68: Chart on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 69: Data Table on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 70: Chart on North America - Year-over-year growth 2021-2026 (%)
    • Exhibit 71: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 8.4 Europe - Market size and forecast 2021-2026
    • Exhibit 72: Chart on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 73: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 74: Chart on Europe - Year-over-year growth 2021-2026 (%)
    • Exhibit 75: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 8.5 Asia - Market size and forecast 2021-2026
    • Exhibit 76: Chart on Asia - Market size and forecast 2021-2026 ($ million)
    • Exhibit 77: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
    • Exhibit 78: Chart on Asia - Year-over-year growth 2021-2026 (%)
    • Exhibit 79: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
    • Exhibit 80: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
    • Exhibit 81: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
    • Exhibit 82: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • Exhibit 83: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 8.7 US - Market size and forecast 2021-2026
    • Exhibit 84: Chart on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 85: Data Table on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 86: Chart on US - Year-over-year growth 2021-2026 (%)
    • Exhibit 87: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 8.8 Germany - Market size and forecast 2021-2026
    • Exhibit 88: Chart on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 89: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 90: Chart on Germany - Year-over-year growth 2021-2026 (%)
    • Exhibit 91: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 8.9 China - Market size and forecast 2021-2026
    • Exhibit 92: Chart on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 93: Data Table on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 94: Chart on China - Year-over-year growth 2021-2026 (%)
    • Exhibit 95: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 8.10 Canada - Market size and forecast 2021-2026
    • Exhibit 96: Chart on Canada - Market size and forecast 2021-2026 ($ million)
    • Exhibit 97: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
    • Exhibit 98: Chart on Canada - Year-over-year growth 2021-2026 (%)
    • Exhibit 99: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 8.11 UK - Market size and forecast 2021-2026
    • Exhibit 100: Chart on UK - Market size and forecast 2021-2026 ($ million)
    • Exhibit 101: Data Table on UK - Market size and forecast 2021-2026 ($ million)
    • Exhibit 102: Chart on UK - Year-over-year growth 2021-2026 (%)
    • Exhibit 103: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 8.12 Market opportunity by geography
    • Exhibit 104: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Exhibit 105: Impact of drivers and challenges in 2021 and 2026
  • 9.4 Market trends

10 Vendor Landscape

  • 10.1 Overview
  • 10.2 Vendor landscape
    • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 10.3 Landscape disruption
    • Exhibit 107: Overview on factors of disruption
  • 10.4 Industry risks
    • Exhibit 108: Impact of key risks on business

11 Vendor Analysis

  • 11.1 Vendors covered
    • Exhibit 109: Vendors covered
  • 11.2 Market positioning of vendors
    • Exhibit 110: Matrix on vendor position and classification
  • 11.3 Abcam plc
    • Exhibit 111: Abcam plc - Overview
    • Exhibit 112: Abcam plc - Product / Service
    • Exhibit 113: Abcam plc - Key news
    • Exhibit 114: Abcam plc - Key offerings
  • 11.4 Agilent Technologies Inc.
    • Exhibit 115: Agilent Technologies Inc. - Overview
    • Exhibit 116: Agilent Technologies Inc. - Business segments
    • Exhibit 117: Agilent Technologies Inc. - Key news
    • Exhibit 118: Agilent Technologies Inc. - Key offerings
    • Exhibit 119: Agilent Technologies Inc. - Segment focus
  • 11.5 Danaher Corp.
    • Exhibit 120: Danaher Corp. - Overview
    • Exhibit 121: Danaher Corp. - Business segments
    • Exhibit 122: Danaher Corp. - Key news
    • Exhibit 123: Danaher Corp. - Key offerings
    • Exhibit 124: Danaher Corp. - Segment focus
  • 11.6 Enzo Biochem Inc.
    • Exhibit 125: Enzo Biochem Inc. - Overview
    • Exhibit 126: Enzo Biochem Inc. - Key offerings
  • 11.7 Merck KGaA
    • Exhibit 127: Merck KGaA - Overview
    • Exhibit 128: Merck KGaA - Business segments
    • Exhibit 129: Merck KGaA - Key news
    • Exhibit 130: Merck KGaA - Key offerings
    • Exhibit 131: Merck KGaA - Segment focus
  • 11.8 New England Biolabs Inc.
    • Exhibit 132: New England Biolabs Inc. - Overview
    • Exhibit 133: New England Biolabs Inc. - Product / Service
    • Exhibit 134: New England Biolabs Inc. - Key offerings
  • 11.9 PerkinElmer Inc.
    • Exhibit 135: PerkinElmer Inc. - Overview
    • Exhibit 136: PerkinElmer Inc. - Business segments
    • Exhibit 137: PerkinElmer Inc. - Key news
    • Exhibit 138: PerkinElmer Inc. - Key offerings
    • Exhibit 139: PerkinElmer Inc. - Segment focus
  • 11.10 Promega Corp.
    • Exhibit 140: Promega Corp. - Overview
    • Exhibit 141: Promega Corp. - Product / Service
    • Exhibit 142: Promega Corp. - Key offerings
  • 11.11 Thermo Fisher Scientific Inc.
    • Exhibit 143: Thermo Fisher Scientific Inc. - Overview
    • Exhibit 144: Thermo Fisher Scientific Inc. - Business segments
    • Exhibit 145: Thermo Fisher Scientific Inc. - Key news
    • Exhibit 146: Thermo Fisher Scientific Inc. - Key offerings
    • Exhibit 147: Thermo Fisher Scientific Inc. - Segment focus
  • 11.12 Vector Laboratories Inc.
    • Exhibit 148: Vector Laboratories Inc. - Overview
    • Exhibit 149: Vector Laboratories Inc. - Product / Service
    • Exhibit 150: Vector Laboratories Inc. - Key offerings

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Exhibit 151: Inclusions checklist
    • Exhibit 152: Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Exhibit 153: Currency conversion rates for US$
  • 12.4 Research methodology
    • Exhibit 154: Research methodology
    • Exhibit 155: Validation techniques employed for market sizing
    • Exhibit 156: Information sources
  • 12.5 List of abbreviations
    • Exhibit 157: List of abbreviations
  • are taken in local currencies, if not available in US dollars, for each country and vendor and then converted to US dollars using the yearly average currency exchange rate of 2021, the base year. This implies that the figures reflect industry trends, not distorted by fluctuations in international exchange rates.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact Us:

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:?media@technavio.com
Website:?www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nucleic-acid-labeling-market-analysis-global-industry-trends--forecast-cagr-7-58-by-2026---technavio-segmentation-based-on-application-end-user-and-geography-301620683.html

SOURCE Technavio

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article